The label for Metformin Hydrochloride now includes a boxed warning regarding lactic acidosis, effective May 21, 2026. This significant label revision highlights the serious and potentially fatal risks associated with metformin-associated lactic acidosis, which has been observed in postmarketing cases.
What this means
The implementation of a boxed warning, also known as a Black Box Warning, represents the most stringent safety alert issued by the U.S. Food and Drug Administration (FDA) for prescription medications. Its presence on the Metformin Hydrochloride label signifies that the drug carries serious or potentially life-threatening risks that warrant prominent disclosure. Specifically, this warning addresses lactic acidosis, a rare but severe metabolic complication. The FDA's decision to add this warning is based on postmarketing cases of metformin-associated lactic acidosis, which have been documented to result in critical health outcomes. These outcomes include death, as well as significant physiological disturbances such as hypothermia, hypotension, and resistant bradyarrhythmias. For healthcare professionals, this means an increased imperative to carefully assess patient risk factors before initiating or continuing Metformin Hydrochloride therapy. It also necessitates heightened vigilance for the signs and symptoms of lactic acidosis, particularly given that its onset is often subtle. Early recognition and intervention are paramount to improving patient prognosis. Patients receiving Metformin Hydrochloride should be thoroughly educated about the symptoms of lactic acidosis and advised to seek immediate medical attention if they experience any concerning signs. This label revision reinforces the critical importance of adhering to prescribing guidelines, including monitoring renal function and identifying contraindications, to minimize the risk of this serious adverse event.
Source
This information regarding the label revision for Metformin Hydrochloride was provided by the FDA. The updated label, effective May 21, 2026, is accessible via the DailyMed database hosted on dailymed.nlm.nih.gov.